Plexium, Inc. (Plexium), a leading next-generation targeted protein degradation company, today announced that initial Phase 1 clinical results with PLX-4545, a selective IKZF2 molecular glue degrader, ...
As health care costs continue to rise, artificial intelligence (AI)-driven solutions are emerging as a powerful tool for ...
A peek behind the scenes at UL Research Institutes, where researchers are taking on the biggest threats to our environment, ...
Marginalized people often bear the brunt of environmental injustices. An annual conference in New Orleans is shaping young ...
1d
Scientists should experiment with creative ways of communicating their work to inspire action to protect the natural world, ...
Nearly 2,000 scientists, engineers and researchers penned an open letter this week to the Trump administration calling for a ...
Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced 11 oral and poster presentations ...
BSU students found recent success at the 11th annual Posters at the Capitol event in St. Paul, with two undergraduate ...
Once you reach a certain level of wealth, you may be inclined to treat yourself to different luxuries. That could mean taking ...
Lab network revenue increased by 33% year over year, reflecting strong demand for ColoAlert® in Europe Operating loss ...
Secondary endpoints in the MINDFuL trial include the CDR-SB, E-Cog, ADL and Neuropsychiatric Inventory (NPI) instruments, ...
One leading botanist is scouring remote corners of the earth to find new species that could keep our mugs full ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback